Articles tagged with 'CedarsScience' | Cedars-Sinai Medical Center

Investigators from the Smidt Heart Institute at Cedars-Sinai have found that community-level socioeconomic disparities are associated with worse three-year survival rates for patients with degenerative mitral regurgitation who had valve repair surger...

A large nationwide survey of 89,000 people conducted by Cedars-Sinai investigators found the prevalence of irritable bowel syndrome (IBS) to be higher than previously reported: 6.1% compared with 4.7% to 5.3% in studies of significantly smaller sampl...

Investigators from the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Cedars-Sinai Cancer have collaborated to co-develop and test a new version of the chemotherapy workhorse doxorubicin. Their study, published in the peer-review...

Investigators from Cedars-Sinai Cancer found that Black women with a low-risk form of endometrial cancer were less likely than white women with the same cancer to have a hysterectomy, and less likely to survive their cancer. The study, published in t...

Two new publications from Cedars-Sinai neuroscientists are helping to advance scientific understanding of the complex molecular and cellular processes involved in Alzheimer’s disease—and the body’s innate immune mechanisms for fighting against the co...

Investigators from The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, have determined that a combination of drugs that act on the immune system in distinct ways improves survival for patients with the deadliest form of sk...

Sex differences in the risk and manifestation of disease are increasingly being explored in the search for effective treatments. Teasing out this variable is often overlooked in complex disease genetics, according to Cedars-Sinai investigators who ar...

Cedars-Sinai regenerative medicine investigators have joined with colleagues from seven other regenerative medicine institutes in the Los Angeles region to form a new consortium that will share resources and maximize the impact of state funding.“The ...

Throughout a dedicated career, Stephan Targan, MD, has chiseled away at a condition once considered monolithic: inflammatory bowel disease (IBD). He and his colleagues have uncovered biomarkers that are used to better classify and treat patients, dev...

Cedars-Sinai investigators have identified rare genetic variants that might make some young people more likely to experience sudden cardiac arrest than others—but noted a lower rate for these variants than reported in previous studies. The findings w...

The 2023 Cedars-Sinai Rubenstein Award for Excellence in Resident Research has been awarded to Cecilia Leggett, MD, for her work with point-of-care ultrasound using personal devices; and Anthony Nguyen, MD, PhD, for his cancer research on the tumor m...

Replicating human organs using stem cells and lab-on-a-chip technology can revolutionize the way diseases and potential treatments are studied, according to two new papers by Cedars-Sinai investigators.Stem cells are cells that have the potential to ...

Investigators at Cedars-Sinai and the National Institute of Neurological Disorders and Stroke have pioneered a way to monitor the self-repair of brain lesions in a nonhuman primate model of multiple sclerosis (MS). Their study, published in the peer-...

By studying the cells that line the intestines, Cedars-Sinai investigators have discovered a biological process that helps these cells repair themselves. The findings, published in the journal Cellular and Molecular Gastroenterology and Hepatology, i...

Aaron Denmark always wanted to be a doctor but assumed he didn’t have what it would take to get into medical school. After graduating from California State University, Dominguez Hills, in 2021, he enrolled in an internship with Cedars-Sinai, thinking...

A new study by investigators from the Smidt Heart Institute at Cedars-Sinai suggests long COVID-19 might be caused by a dysfunction of the immune system. The study, published in BMC Infectious Diseases, found that after people with long COVID-19 rece...

Investigators at Cedars-Sinai have created computer-generated models to bridge the gap between “test tube” data about neurons and the function of those cells in the living brain. Their study, published in the peer-reviewed journal Nature Communicatio...

Cedars-Sinai investigators are developing a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using engineered stem cells that may eventually lead to personalized treatments. The new approach uses cells derived from huma...

Virtual reality (VR) is not just for gaming and entertainment. As it turns out, extended reality (XR) technologies can help support human health and the wellbeing of patients who suffer from a variety of debilitating and chronic conditions, including...

Everything physicians and investigators know about medicine, from which drugs to prescribe to how to perform surgeries, is based on research. But for decades, most of this work has left out female participants. This means experts don’t have much to r...

A new study by Cedars-Sinai investigators found that people whose blood pressure fluctuated while they were in the hospital were at greater risk for developing Alzheimer’s disease or other types of dementia than people whose blood pressure remained s...

Jessica Carriere, PhD, is a postdoc in the laboratory of Christian Stehlik, PhD, MS, and Andrea Dorfleutner, PhD, MS, professors of Pathology and Laboratory Medicine and Biomedical Sciences at Cedars-Sinai. Carriere, who was previously a fellow at Ce...

When pharmacy staff develop an accurate medication list for high-risk patients being admitted to a hospital, medication errors—that could have led to substantial complications or even death—are significantly reduced, according to a new study led by C...

Cedars-Sinai has established a new Human Microbiome Research Institute that will support investigators studying how the microbiome, the diverse collection of bacteria, fungi and viruses that live in and on the human body, plays a role in health.Suzan...

Alberto Ayala-Sarmiento, PhD, a postdoctoral scientist in the Breunig Lab, is focusing primarily on tumor modeling through genetic engineering and the development of new transgenesis tools. Ayala-Sarmiento was one of three Cedars-Sinai postdocs who w...

RESOURCESHigh Risk for Hypoglycemia Guideline Resources Ask the Expert: A Patient Approach to Preventing Hypoglycemia: A Conversation with Roma Gianchandani, MD 

Alessandra Ciullo, PhD, who is investigating how certain molecules repair the heart after a heart attack, and Zhongzheng Fu, PhD, whose work helps explain how people learn from mistakes, are the recipients of this year’s Cedars-Sinai Bohdan (Danny) M...

Cardiac electrophysiologist Eric Braunstein, MD, who joined the Smidt Heart Institute at Cedars-Sinai late last year, recently published a first-of-its kind case study in the peer-reviewed medical journal Heart Rhythm Case Reports. The case study sho...

Cedars-Sinai is the coordinating center for the newly launched Southern California Cystic Fibrosis Research Program. The program will support research into personalized treatments, with an emphasis on identifying unique cystic fibrosis mutations in p...

Cedars-Sinai’s Efforts to Combat Lower Back Pain Get $2 Million Boost From CIRMInvestigators at Cedars-Sinai have received a $2 million grant from the California Institute for Regenerative Medicine (CIRM) to develop a new cell therapy that helps impr...